EUSA Pharma
Sector: Pharmaceuticals
Location: Oxford, United Kingdom
Status: Realized
EUSA marketed products, with infrastructure and sales force in European markets, and modest operations and sales in the United States. EW was backing Bryan Morton, the former CEO of EUSA Pharma, in a transaction to acquire several key assets of his old company to serve as a platform for a buy-and-build strategy. The goal with the investment was to transform the company into a growing trans-Atlantic specialty pharmaceutical company through acquiring and in-licensing products and companies with European revenue to leverage the current European infrastructure, as well as acquiring and in-licensing EU and US rights to specialty products that are in late-stage clinical trials and could be launched to accelerate revenue growth. EUSA Pharma was acquired by Recordati in March 2022.
